Creating molecules that can target and destroy cancer proteins
Evolved Molecules that Destroy Cancer Relevant Proteins
This study is working on new tools that can help target and break down proteins related to cancer, with the goal of making cancer treatments faster and more affordable for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Foundation for Applied Molecular Evolutn NIH-funded |
| Lab location | 1 site (Alachua, United States) |
| Project ID | NIH-10916087 on NIH RePORTER |
What this research studies
This research focuses on developing innovative molecules called AEGISbodies and AEGISCleavers that can bind to and cleave cancer-relevant proteins. By utilizing a unique laboratory evolution technique, the researchers aim to produce these molecules at a significantly lower cost and faster pace than traditional methods. The approach involves using an artificially expanded genetic information system to create highly stable and functional biopolymers that can specifically target cancer cells. Patients may benefit from the advancements in cancer treatment that these new reagents could facilitate.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with cancers that express specific proteins targeted by the AEGIS technology, such as breast or liver cancer.
Not a fit: Patients with cancers that do not express the targeted proteins or those who are not eligible for experimental treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and affordable cancer treatments by targeting and destroying specific cancer proteins.
How similar studies have performed: Other research has shown promise in using similar molecular targeting approaches in cancer treatment, indicating potential for success in this novel application.
Where this research is happening
Alachua, United States
- Foundation for Applied Molecular Evolutn — Alachua, United States (Active)
Researchers
- Principal investigator: Biondi, Elisa — Foundation for Applied Molecular Evolutn
- Study coordinator: Biondi, Elisa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.